- EU's IMI Plans Projects On 'Big Data' In Health Outcomes
- Afferent raises $55m from IPO-focused investors
- Australian cash for new drugs comes with strings
- What else will 2Q 2015 bring?
- ICAAC 2015: Cempra CEO Sees Solithromycin Potential Beyond Infectious Diseases
- INTERVIEW: Clinuvel's Philippe Wolgen on Scenesse and the patient factor